These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 31138497)
1. Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections. Banaschewski B; Verma D; Pennings LJ; Zimmerman M; Ye Q; Gadawa J; Dartois V; Ordway D; van Ingen J; Ufer S; Stapleton K; Hofmann T J Cyst Fibros; 2019 Sep; 18(5):714-720. PubMed ID: 31138497 [TBL] [Abstract][Full Text] [Related]
2. Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection. Kunkel M; Doyle-Eisele M; Kuehl P; Rotermund K; Hittinger M; Ufer S; Reed M; Grant M; Hofmann T Antimicrob Agents Chemother; 2023 Feb; 67(2):e0114422. PubMed ID: 36648233 [TBL] [Abstract][Full Text] [Related]
3. Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection. Martiniano SL; Wagner BD; Levin A; Nick JA; Sagel SD; Daley CL Chest; 2017 Oct; 152(4):800-809. PubMed ID: 28483608 [TBL] [Abstract][Full Text] [Related]
4. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis. Schwartz M; Fisher S; Story-Roller E; Lamichhane G; Parrish N Microb Drug Resist; 2018 Oct; 24(8):1191-1197. PubMed ID: 29368988 [TBL] [Abstract][Full Text] [Related]
5. Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127 [TBL] [Abstract][Full Text] [Related]
7. Minimal Inhibitory Concentration of Clofazimine Among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment Outcome. Kwak N; Whang J; Yang JS; Kim TS; Kim SA; Yim JJ Chest; 2021 Feb; 159(2):517-523. PubMed ID: 32712225 [TBL] [Abstract][Full Text] [Related]
8. Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection. Rose SJ; Neville ME; Gupta R; Bermudez LE PLoS One; 2014; 9(9):e108703. PubMed ID: 25264757 [TBL] [Abstract][Full Text] [Related]
9. Administration and monitoring of clofazimine for NTM infections in children with and without cystic fibrosis. Cameron LH; Peloquin CA; Hiatt P; Mann M; Starke JR; Faircloth J; McNeil JC; Patel A; Ruiz F J Cyst Fibros; 2022 Mar; 21(2):348-352. PubMed ID: 34479810 [TBL] [Abstract][Full Text] [Related]
10. In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease. van Ingen J; Totten SE; Helstrom NK; Heifets LB; Boeree MJ; Daley CL Antimicrob Agents Chemother; 2012 Dec; 56(12):6324-7. PubMed ID: 23027189 [TBL] [Abstract][Full Text] [Related]
11. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin. Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of PBTZ169 and pretomanid against Mycobacterium avium, Zheng L; Qi X; Zhang W; Wang H; Fu L; Wang B; Chen X; Chen X; Lu Y Front Cell Infect Microbiol; 2023; 13():1115530. PubMed ID: 37077530 [TBL] [Abstract][Full Text] [Related]
13. The role of amikacin in the treatment of nontuberculous mycobacterial disease. Raaijmakers J; Schildkraut JA; Hoefsloot W; van Ingen J Expert Opin Pharmacother; 2021 Oct; 22(15):1961-1974. PubMed ID: 34292097 [No Abstract] [Full Text] [Related]
14. Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease. Kang N; Jeon K; Kim H; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ; Jhun BW Chest; 2021 Aug; 160(2):436-445. PubMed ID: 33621600 [TBL] [Abstract][Full Text] [Related]
18. New insights in the treatment of nontuberculous mycobacterial pulmonary disease. Ruth MM; van Ingen J Future Microbiol; 2017 Oct; 12():1109-1112. PubMed ID: 28972416 [No Abstract] [Full Text] [Related]
19. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases]. Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567 [TBL] [Abstract][Full Text] [Related]
20. The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults. Khan O; Chaudary N Drug Des Devel Ther; 2020; 14():2287-2294. PubMed ID: 32606598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]